Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 12.71M $1.20B Dec. 31, 2015
Wellington Management Company 10.66M $1.00B Dec. 31, 2015
Vanguard 5.05M $475.29M Dec. 31, 2015
BAILLIE GIFFORD & CO 2.73M $256.79M Dec. 31, 2015
Franklin Resources 2.14M $207.43M Dec. 31, 2014
Capital World Investors^ 1.94M $182.50M Dec. 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.92M $180.83M Dec. 31, 2015
Columbia Wanger Asset Management 1.91M $122.87M Dec. 31, 2013
HealthCor Management 1.80M $16.87M June 30, 2011
BlackRock Institutional Trust Company, N.A. 1.77M $166.90M Dec. 31, 2015
BlackRock Fund Advisors 1.73M $162.50M Dec. 31, 2015
STATE STREET CORPORATION 1.67M $157.57M Dec. 31, 2015
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
First Trust Advisors 1.56M $125.55M Sept. 30, 2015
Jennison Associates 1.49M $140.23M Dec. 31, 2015
Gilder, Gagnon, Howe & Co 1.48M $139.08M Dec. 31, 2015
HealthCor Management 1.45M $35.34M March 31, 2013
Falcon Edge Capital 1.37M $132.67M Dec. 31, 2014
Bridger Management 1.37M $33.31M March 31, 2013
Abingworth 1.31M $24.69M Sept. 30, 2012
MORGAN STANLEY 1.30M $155.46M June 30, 2015
Camber Capital Management 1.28M $14.17M March 31, 2012
T. Rowe Price Associates 1.24M $116.53M Dec. 31, 2015